Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate
Clinical trial NCT01444820 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01444820
- Sponsor
- Sir Mortimer B. Davis - Jewish General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2026-01-01
- Enrollment
- 329
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.